What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Disease
His primary scientific interests are in Internal medicine, Gastroenterology, Cirrhosis, Surgery and Fatty liver.
His Internal medicine research includes elements of Endocrinology and Ribavirin, Sofosbuvir.
The Gastroenterology study combines topics in areas such as Liver biopsy, Hepatitis C virus, Immunology, Placebo and Primary sclerosing cholangitis.
His Cirrhosis research is multidisciplinary, incorporating elements of Hemochromatosis, Liver transplantation, Biopsy, Pathology and Liver disease.
The study incorporates disciplines such as Chronic liver disease and Intensive care medicine in addition to Fatty liver.
His studies deal with areas such as Fibrosis and Hepatology as well as Nonalcoholic fatty liver disease.
His most cited work include:
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis (1964 citations)
- Sofosbuvir for previously untreated chronic hepatitis C infection (1448 citations)
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial (1266 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Gastroenterology, Cirrhosis, Liver disease and Nonalcoholic fatty liver disease.
His biological study deals with issues like Ribavirin, which deal with fields such as Adverse effect.
The concepts of his Gastroenterology study are interwoven with issues in Fibrosis, Placebo, Liver biopsy and Sofosbuvir.
His studies in Cirrhosis integrate themes in fields like Hemochromatosis, Hepatocellular carcinoma and Immunology.
Hereditary hemochromatosis is closely connected to Pathology in his research, which is encompassed under the umbrella topic of Liver disease.
His Nonalcoholic fatty liver disease study combines topics in areas such as Steatosis and Hepatology.
He most often published in these fields:
- Internal medicine (70.31%)
- Gastroenterology (50.46%)
- Cirrhosis (17.85%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (70.31%)
- Gastroenterology (50.46%)
- Cirrhosis (17.85%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Internal medicine, Gastroenterology, Cirrhosis, Nonalcoholic fatty liver disease and In patient.
Much of his study explores Internal medicine relationship to Placebo.
His research integrates issues of Liver biopsy, Primary sclerosing cholangitis, Obeticholic acid and Sofosbuvir in his study of Gastroenterology.
His work deals with themes such as Regimen and Voxilaprevir, which intersect with Sofosbuvir.
The Cirrhosis study combines topics in areas such as Hepatocellular carcinoma, Interquartile range, Disease and Liver function tests.
Kris V. Kowdley works mostly in the field of Nonalcoholic fatty liver disease, limiting it down to concerns involving Steatosis and, occasionally, Prospective cohort study, Transient elastography and Metabolic syndrome.
Between 2016 and 2021, his most popular works were:
- A Randomized, Placebo-Controlled Trial of Cenicriviroc for Treatment of Nonalcoholic Steatohepatitis with Fibrosis (322 citations)
- Sofosbuvir, velpatasvir, and voxilaprevir for previously treated HCV infection (300 citations)
- Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis (172 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
Internal medicine, Gastroenterology, Nonalcoholic fatty liver disease, Cirrhosis and Fibrosis are his primary areas of study.
His Internal medicine research integrates issues from Placebo and Sofosbuvir.
His Sofosbuvir research is multidisciplinary, relying on both Ledipasvir, Voxilaprevir and Hepatitis C.
His Gastroenterology study incorporates themes from Liver biopsy, Obeticholic acid and Stage.
His Nonalcoholic fatty liver disease research is multidisciplinary, incorporating elements of Steatosis, Endocrinology, Transient elastography, Confidence interval and Biopsy.
His research in Cirrhosis intersects with topics in Bilirubin, Liver transplantation and Hazard ratio.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
